For instance, many cancer biomarkers in the clinic are glycoproteins, including CEA in CRC [6], carbohydrate antigen 19-9 (CA19-9) in gastrointestinal cancer [23], and prostate-specific antigen (PSA) in prostate cancer [24]. This evidence concerns the gene KLK3 and prostate carcinoma.